Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share.
Symbol
BNR on Nasdaq
Shares outstanding
9,041,375
Price per share
$33.42
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,688,148
Total reported value
$34,027,626
% of total 13F portfolios
0%
Share change
+277,347
Value change
+$5,737,183
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CRCM LP 5.4% $5,963,583 486,426 CRCM LP 16 Dec 2025

As of 31 Dec 2025, 14 institutional investors reported holding 1,688,148 shares of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR). This represents 19% of the company’s total 9,041,375 outstanding shares.

Top 19 Institutional Shareholders

The largest institutional shareholders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) together control 19% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Kynam Capital Management, LP 11% 994,883 0% 1.3% $20,046,892
CRCM LP 5.4% 491,426 +122% 3.3% $9,902,234
Amova Asset Management Americas, Inc. 0.35% 31,807 -8.7% 0.01% $652,362
Sumitomo Mitsui Trust Group, Inc. 0.35% 31,807 -8.7% 0% $640,911
Prospera Financial Services Inc 0.34% 31,185 +26% 0.01% $628,371
RENAISSANCE TECHNOLOGIES LLC 0.34% 31,117 -1.9% 0% $627,008
BANK OF AMERICA CORP /DE/ 0.32% 29,178 0% 0% $587,937
Redwood Wealth Management Group, LLC 0.22% 20,023 0.17% $403,463
MORGAN STANLEY 0.13% 11,840 -47% 0% $238,576
MARSHALL WACE, LLP 0.12% 10,903 0% $219,695
BNP PARIBAS FINANCIAL MARKETS 0.03% 2,800 0% 0% $56,420
UBS Group AG 0.01% 1,168 +35% 0% $23,535
BlackRock, Inc. 0% 10 0% 0% $202
CITIGROUP INC 0% 1 0% $20
SkyView Investment Advisors, LLC 0% 0 -100% $0
JPMORGAN CHASE & CO 0% 0 -100% $0
China Universal Asset Management Co., Ltd. 0% 0 -100% $0
HSG Holding Ltd 0.23% 21,212 0% $870,965
SHEN NEIL NANPENG 0.01% 885 0% $36,338

Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing ten Class A Ordinary Shares, par value $0.0002 per share. (BNR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,688,148 $34,027,626 +$5,737,183 $20.15 14
2025 Q3 1,430,998 $12,424,668 +$172,458 $8.65 16
2025 Q2 1,445,762 $4,571,204 -$2,836,549 $3.16 17
2025 Q1 2,204,546 $9,648,455 -$654,410 $4.50 18
2024 Q4 2,344,607 $15,838,361 +$2,155,649 $6.75 21
2024 Q3 2,025,359 $6,615,771 -$63,267 $3.27 16
2024 Q2 2,034,289 $13,034,824 +$13,034,824 $6.45 16